Li Chunguang, Li Bin, Yang Yang, Li Zhigang
Department of Thoracic Surgery, Section of Esophageal Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
J Gastrointest Oncol. 2023 Feb 28;14(1):11-21. doi: 10.21037/jgo-22-985. Epub 2023 Feb 21.
Whether extended robot-assisted esophagectomy with thoracic duct resection (RAE-TDR) has a favorable effect on esophageal cancer patients is not yet known. This study sought to analyze the safety and efficiency of RAE-TDR.
From January 2019 to July 2020, 73 thoracic duct (TD)-resected and 127 TD-preserved consecutive patients who received standard RAE McKeown surgery were enrolled in this study. The perioperative-related indicators of recurrence-free survival (RFS) and overall survival (OS) at 1-year were compared between the 2 groups.
In relation to morbidity, the Clavien-Dindo (CD) classifications for grades greater than or equal to II-III were similar between the 2 groups (P>0.05). The number of retrieved total lymph nodes (LNs) and mediastinal nodes were significantly higher in the TD-resected group than in the TD-preserved group (total lymph nodes: 29.0±11.1 25.1±8.5, P=0.006; mediastinal nodes: 19.5±8.0 16.1±5.5, P=0.002). Additionally, more metastatic TD-related LNs were harvested in cT3-4 patients (2.3±3.7 1.7±2.8; P=0.21). The rates of LN recurrence and local recurrence were similar between the 2 groups (LN recurrence: 6.8% 7.1%, P>0.99; local recurrence: 1.4% 2.4%, P>0.99). The OS and RFS at 1-year were equivalent regardless of the TD procedure at each stage (P>0.05). However, the rate of hematogenous metastasis in the TD-resected group was significantly elevated (17.8% 7.9%; P=0.034).
RAE-TDR may help to improve total and metastatic LN harvest, especially in patients with advanced esophageal squamous cell carcinoma (ESCC) without increasing the intra- and post-operative adverse events. However, RAE-TDR did not lead to a decrease in the local recurrence rate within the short-term follow-up period. Whether the increase in distant metastasis rate in the TD-resected group was associated with relevant immune system damage is unclear. Thus, nonselective RAE-TDR is not routinely recommended.
扩大的机器人辅助食管癌切除术联合胸导管切除术(RAE-TDR)对食管癌患者是否具有良好效果尚不清楚。本研究旨在分析RAE-TDR的安全性和有效性。
2019年1月至2020年7月,本研究纳入了73例行胸导管(TD)切除术和127例行TD保留术且接受标准RAE McKeown手术的连续患者。比较两组患者1年无复发生存期(RFS)和总生存期(OS)的围手术期相关指标。
在发病率方面,两组中Clavien-Dindo(CD)分级大于或等于II-III级的情况相似(P>0.05)。TD切除组回收的总淋巴结(LN)和纵隔淋巴结数量显著高于TD保留组(总淋巴结:29.0±11.1对25.1±8.5,P=0.006;纵隔淋巴结:19.5±8.0对16.1±5.5,P=0.002)。此外,cT3-4患者中收获的与TD相关的转移LN更多(2.3±3.7对1.7±2.8;P=0.21)。两组的LN复发率和局部复发率相似(LN复发:6.8%对7.1%,P>0.99;局部复发:1.4%对2.4%,P>0.99)。无论各阶段的TD手术如何,1年时的OS和RFS相当(P>0.05)。然而,TD切除组的血行转移率显著升高(17.8%对7.9%;P=0.034)。
RAE-TDR可能有助于提高总LN和转移LN的收获量,尤其是在晚期食管鳞状细胞癌(ESCC)患者中,且不增加术中和术后不良事件。然而,在短期随访期内,RAE-TDR并未导致局部复发率降低。TD切除组远处转移率的增加是否与相关免疫系统损伤有关尚不清楚。因此,不常规推荐非选择性RAE-TDR。